Mizuho Initiates Coverage On Tarsus Pharmaceuticals with Outperform Rating, Announces Price Target of $100
Benzinga Newsdesk 11 months ago
NewsPrice TargetInitiationAnalyst Ratings
Mizuho analyst Graig Suvannavejh initiates coverage on Tarsus Pharmaceuticals (NASDAQ:TARS) with a Outperform rating and announces Price Target of $100.
Mizuho analyst Graig Suvannavejh initiates coverage on Tarsus Pharmaceuticals (NASDAQ:TARS) with a Outperform rating and announces Price Target of $100.